Google parent company Alphabet Inc. has launched a new company in London called Isomorphic Labs. The company aims to use AI (artificial intelligence) for drug discovery and medicine to find cures for some of humanity’s most devastating diseases. Demis Hassabis will be the CEO of Isomorphic Labs. Hassabis is the CEO and co-founder of DeepMind, another Alphabet subsidiary that used AI to predict the 3D structure of a protein directly from its amino acid sequence.
The London-based Isomorphic Labs will work on the most important applications of AI — in the field of biological and medical research. The company aims to use AI to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases. The new venture also plans to partner with biomedical and pharmaceutical companies, using artificial intelligence to discover new medicinal advancements.
Important takeaways for all competitive exams
Honorable PM Narendra Modi presented Russian President Vladimir Putin with a Russian translation of the…
The East Zone bagged the Duleep Trophy trophy 2026-27 following the draw between South Zone…
Since the time of the first summit held in 2009, there has been much change…
The group of BRICS countries has grown considerably, with 11 leading emerging economies belonging to…
As India is organizing the 18th BRICS Summit in New Delhi from September 12 to…
The Reserve Bank of India (RBI) has come up with an innovative digital payment features…